TITLE

Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment

AUTHOR(S)
Markovic, Svetomir N.; Erickson, Lori A.; Rao, Ravi D.; Weenig, Roger H.; Barbara A. Pockaj; Bardia, Aditya; Vachon, Celine M.; Schild, Steven E.; McWilliams, Robert R.; Hand, Jennifer L.; Laman, Susan D.; Kottschade, Lisa A.; Maples, William J.; Pittelkow, Mark R.; Pulido, Jose S.; Cameron, J. Douglas; Creagan, Edward T.
PUB. DATE
April 2007
SOURCE
Mayo Clinic Proceedings;Apr2007, Vol. 82 Issue 4, p490
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Critical to the clinical management of a patient with malignant melanoma is an understanding of its natural history. As with most malignant disorders, prognosis is highly dependent on the clinical stage (extent of tumor burden) at the time of diagnosis. The patient's clinical stage at diagnosis dictates selection of therapy. We review the state of the art in melanoma staging, prognosis, and therapy. Substantial progress has been made in this regard during the past 2 decades. This progress is primarily reflected in the development of sentinel lymph node biopsies as a means of reducing the morbidity associated with regional lymph node dissection, increased understanding of the role of neoangiogenesis in the natural history of melanoma and its potential as a treatment target, and emergence of innovative multimodal therapeutic strategies, resulting in significant objective response rates in a disease commonly believed to be drug resistant. Although much work remains to be done to improve the survival of patients with melanoma, clinically meaningful results seem within reach.
ACCESSION #
24851324

 

Related Articles

  • Adult hepatoblastoma successfully treated with multimodal treatment. Nakamura, Shinji; Sho, Masayuki; Kanehiro, Hiromichi; Tanaka, Toshihiro; Kichikawa, Kimihiko; Nakajima, Yoshiyuki // Langenbeck's Archives of Surgery;Nov2010, Vol. 395 Issue 8, p1165 

    Purpose: Adult hepatoblastoma is rare and the prognosis is extremely poor. Although surgery offers the only chance for cure, it often recurs even after complete resection. To date, no therapeutic strategy has been established. We report here a rare case of adult hepatoblastoma successfully...

  • Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination. Schreibelt, Gerty; Creemers, Jeroen H A; Figdor, Carl G; Bol, Kalijn F; de Vries, I Jolanda M; Aarntzen, Erik H J G; Hout, Florentien E M in 't; Lesterhuis, W Joost; Gerritsen, Winald R; Bonenkamp, Johannes J; de Wilt, Johannes H W; Grunhagen, Dirk J; Verhoef, Cornelis; Punt, Cornelis J A // OncoImmunology;Jan2016, Vol. 5 Issue 1, p1 

    Melanoma patients with regional metastatic disease are at high risk for recurrence and metastatic disease, despite radical lymph node dissection (RLND). We investigated the immunologic response and clinical outcome to adjuvant dendritic cell (DC) vaccination in melanoma patients with regional...

  • Adult Brainstem Gliomas. REYES-BOTERO, GERMAN; MOKHTARI, KARIMA; MARTIN-DUVERNEUIL, NADINE; DELATTRE, JEAN-YVES; LAIGLE-DONADEY, FLORENCE // Oncologist;Mar2012, Vol. 17 Issue 3, p388 

    Brainstem gliomas are uncommon in adults and account for only 1%-2% of intracranial gliomas. They represent a heterogeneous group of tumors that differ from those found in their pediatric counterparts. In adults, a low-grade phenotype predominates, which is a feature that likely explains their...

  • Metastatic Inguinal Lymphadenopathy. Hajdarbegovic, Enes; Balak, Deepak // New England Journal of Medicine;4/19/2012, Vol. 366 Issue 16, p1526 

    The article describes the case of an adult male presenting with metastatic inguinal lymphadenopathy. The patient showed a 10-cm ulcerated lesion located on his lower back and multiple subcutaneous areas of swelling in both inguinal regions. Analysis of a biopsy specimen from the lesion on the...

  • Sentinel node biopsy in melanoma. Petrou, Ilya // Dermatology Times;Jan2007, Vol. 28 Issue 1, p124 

    The article suggests that performing sentinel lymph node biopsy seems to have no survival advantage in patients with malignant melanoma compared to simply observing melanoma patients after post-primary tumor excision and removing palpable nodes as they appear. Dr. John A. Zitelli discusses the...

  • Ultrasound-guided biopsy. Petrou, Ilya // Dermatology Times;Mar2009, Vol. 30 Issue 3, p76 

    The article offers information on a new ultrasound-guided fine-needle aspiration cytology (US-FNAC) technique which is used to extract cell from suspected melanoma-infiltrated sentinel lymph nodes. This technique provides a more sophisticated and accurate clinical assessment of sentinel lymph...

  • The value of sentinel lymphadenectomy in radical operative treatment of cervical cancer. Pa�in, Vladimir; Dragojevic, Svetlana; Mikovic, �eljko; �ukic, Milan; Rakic, Sne�ana; Marinkovic, Jelena; Filimonovic, Dejan; Damnjanovic-Pa�in, Barbara // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Jul2009, Vol. 66 Issue 7, p539 

    Background/Aim. Therapy of the early stages of cervical carcinoma is surgical or radiation therapy, and for advanced stages chemoradiotherapy. Pelvic and paraaortic lymphadenectomy in early stages offers the most important prognostic factor for survival. To evaluate the method and possible...

  • Retinopathy Associated with Adjuvant High-Dose Interferon-α2β in a Patient with Resected Melanoma: A Case Report and Review of the Literature. MONZON, JOSE G.; HAMMAD, NAZIK; STEVENS, SAMUEL D.; DANCEY, JANET // Oncologist;Mar2012, Vol. 17 Issue 3, p384 

    Interferon is the only accepted adjuvant treatment for patients with melanoma; hence, oncologists should be aware of the possibility of retinal abnormalities resulting from its use. Interferon-associated retinopathy in patients being treated for resected melanoma is a rare phenomenon with a...

  • Mesantoin Lymphadenopathy Morphologically Simulating Hodgkin's Disease. Doyle, A.P.; Hellstrom, H.R. // Annals of Internal Medicine;Sep63, Vol. 59 Issue 3, p363 

    Presents the case of a 36-year-old man with lymphadenopathy that occurred during the course of Mesantoin therapy. Observation of cells of Reed-Sternberg type in the second biopsy; Lymph node biopsies; Characteristic clinical course of lymphadenopathy.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics